Topics
News
CME/CE
Editorial Advisory Board
Partnerships
Galderma approved for Differin(R) Gel 0.1 percent in Japan
Lausanne, Switzerland - Galderma Pharma S.A. announced that Japan’s Health Labor and Welfare has approved Differin(R) Gel 0.1 percent (adapalene).
Lausanne, Switzerland
- Galderma Pharma S.A. announced that Japan’s Health Labor and Welfare has approved Differin(R) Gel 0.1 percent (adapalene).
The drug, used to treat acne vulgaris, will be marketed in Japan by Galderma KK, the Japanese arm of Galderma.
Related Videos
Related Content
